Heartbeat of the nation
On 15 November 2019 we changed from Australian Red Cross Blood Service to Australian Red Cross Lifeblood.
For regular blood, plasma and platelet donors, nothing much has changed. They still continue to support Australians with generous donations, just as they have for 90 years. Learn about our history
But for some people, our new name is quite literally life-changing. That’s because we’re also helping to facilitate the donation of tissue, organs, breast milk, and other life-saving biological products. Discover our purpose.
So, while you might not notice much of a difference, to someone in need of more than blood, life quite literally depends on Lifeblood.
Lifeblood is governed by the Lifeblood Board, which includes our Chief Executive Shelly Park.
Lifeblood is funded by Australian Governments to provide life-giving blood, plasma, transplantation and biological products for world leading health outcomes.
Lifeblood is an operating division of the Australian Red Cross Society. Lifeblood and the humanitarian arm of the Australian Red Cross Society have separate executive structures and funding but share the values of the International Red Cross and Red Crescent Movement.
Details of the Australian Red Cross Society and its humanitarian work are available on its website
ABOUT LIFEBLOOD
What we do
People
DIVISIONS
| DIVISION | |||
| Donor Services | Manages the collection of blood donations, relationships with donors, contact centre operations, building community relationships and management of facilities. | Finance | To enable the business to make efficient and effective decisions; provide financial governance; leverage technology to delivery agile solutions and actively partner with the business to advance our corporate health. |
| People and Culture | Partners with and enables the business through advancing our safety imperative, aligning people initiatives to support the organisation’s strategic plan and enriching the employee experience. | Information and Communications Technology | Manages the hardware and software needed to efficiently run Lifeblood, including the National Blood Management System (NBMS) and the National Transplant Systems (NTS). |
| Manufacturing and Quality | Processes blood donations, ensuring they are tested and efficiently distributed to meet demand. | Corporate Strategy and Transformation | Supports the organisation through business strategy, policy advice and driving transformational change with an organisation-wide impact. Areas of responsibility include strategic planning, risk management, oversight of national projects portfolio, quality services, marketing, public relations and internal communications, lean strategy and international services. |
| Clinical Services and Research | Supports optimal, safe practices at every stage of the blood journey, from donation to transfusion. Provides clinical oversight of both donor and patient safety relating to blood and tissue products creates and translates unique, world-class knowledge in blood transfusion-related research. | Corporate | Includes the Board Secretary, Legal and Government Relations, the Chief Executive Advisor as well as the Office of the Chief Executive. |
| Business Growth and Innovation | Leverages the strengths and capabilities of our organisation to develop growth opportunities, innovation and future commercial pathways that will position Lifeblood as a recognised leader in its field, both locally and globally, and enhance our transplantation and immunogenetics work. | ||
Services
We draw upon our core strengths of safety, quality, specialised expertise and national infrastructure to help enhance healthcare in Australia to deliver improved patient outcomes.
Publications
Annual report
Each year Australian Red Cross Lifeblood lodges an annual report detailing our financial and performance information gathered over the financial year. These documents are part of the public record.
2018-2019
Lifeblood Annual Report - Financial Statements
2017-2018
Annual Report 2017-2018 - Financial Statements
Previous years
Annual Report 2016–17 – Financial Statements
Strategic plan
Blood and Beyond – Strategy 2023 defines our future direction. Through its three key pillars the strategy clearly sets out how we’ll build on our strong foundations and articulates what needs to be achieved so we can make an even greater contribution to healthcare in Australia.
Blood and Beyond – Strategy 2023
Business plan
The business plan for 2019-20 supports the first year of our strategic plan, Blood and Beyond – Strategy 2023.
Tenders
For information on current tenders and tenders are coming up please see the details below - suppliers are advised to monitor this page for updates.
Tenders are advertised on this web page and may be advertised in other forms of media so please refer to the tender advertisement for registration details.
For other queries, please see the Supplier FAQs.
Tender Name: Blood Grouping Expression of Interest
Tender Description:
Lifeblood is seeking Expressions of Interest (EOI) from commercial suppliers for the supply of instruments for blood grouping including companion reagents, consumables and maintenance services.
Interested parties please register here: (link to https://redcrossbloodau.smartsourceportal.com/SourceWeb.dll/SupplierRegistration.html )
Please direct enquiries to: NationalProcurementAUS@redcrossblood.org.au
Registration Closing date:
4:00 PM AEST on 22 November 2019 4:00 PM AEST
Expected EOI Documentation Release date:
10:00 AM AEST on 25 November 2019
Expression Of Interest Closing date:
4:00 PM AEST on 06 December 2019
Name: Manufacturing and Labelling Automation (Processing Future State) Request for Information (RFI)
Description: The Australian Red Cross Lifeblood wishes to engage with suitably experienced Suppliers with expertise in:
Automated product labelling and vision inspection system
Conveyor systems with capability to scan, sort and track
Manufacturing workflow optimisation
Robotic automation
Suppliers are required to register and enter into a Confidentiality Agreement with Lifeblood in order to receive the RFI documentation for the provision of Manufacturing and Labelling Automation (Processing Future State) Request for Information (RFI)
Interested parties please register by emailing their interest to; Ms Dimitra Marinakis, Manufacturing Program Manager dmarinakis@redcrossblood.org.au
Registration Open date: 9.00am AEST, 2 December 2019
Expected Documentation Release date:
Detailed RFI information will be made available upon registration and execution of the Confidentiality Agreement.
Suppliers will be invited to an information session where details of the process and high level requirements will be discussed.
Site Visits: Not required.
Closing date: RFI closing date is by 5.00pm AEST, 10 January 2020.